Literature DB >> 27383180

[Antiphospholipid syndrome].

C Specker1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27383180     DOI： 10.1007/s00393-016-0153-8

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  37 in total

1.  Hypergammaglobulinemia, circulating anticoagulant, and biologic false positive Wassermann reaction; a study in two cases.

Authors:  A B LAURELL; I M NILSSON
Journal:  J Lab Clin Med       Date:  1957-05

2.  Do patients followed in anticoagulation clinics for antiphospholipid syndrome meet criteria for the disorder?

Authors:  Andrew S Dunn; Peter Kaboli; Thorvardur Halfdanarson; Happy Chan; Rod Hubert; Seth Rosen; Richard H White
Journal:  Thromb Haemost       Date:  2005-09       Impact factor: 5.249

3.  IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study.

Authors:  S R Levine; L Salowich-Palm; K L Sawaya; M Perry; H J Spencer; H J Winkler; Z Alam; J L Carey
Journal:  Stroke       Date:  1997-09       Impact factor: 7.914

4.  [Antiphospholipid syndrome].

Authors:  C Specker
Journal:  Z Rheumatol       Date:  2015-04       Impact factor: 1.372

5.  Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups.

Authors:  Chi Chiu Mok; Sandy Shuk Kuen Tang; Chi Hung To; Michelle Petri
Journal:  Arthritis Rheum       Date:  2005-09

Review 6.  Management of antiphospholipid antibody syndrome: a systematic review.

Authors:  Wendy Lim; Mark A Crowther; John W Eikelboom
Journal:  JAMA       Date:  2006-03-01       Impact factor: 56.272

Review 7.  Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant.

Authors:  M Empson; M Lassere; J Craig; J Scott
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

8.  Primary antiphospholipid syndrome evolving into systemic lupus erythematosus.

Authors:  F Mujic; M J Cuadrado; M Lloyd; M A Khamashta; G Page; G R Hughes
Journal:  J Rheumatol       Date:  1995-08       Impact factor: 4.666

9.  Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.

Authors:  José A Girón-González; Enrique García del Río; Carmen Rodríguez; Javier Rodríguez-Martorell; Ascensión Serrano
Journal:  J Rheumatol       Date:  2004-08       Impact factor: 4.666

10.  Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results.

Authors:  Cecile M Yelnik; Carl A Laskin; T Flint Porter; D Ware Branch; Jill P Buyon; Marta M Guerra; Michael D Lockshin; Michelle Petri; Joan T Merrill; Lisa R Sammaritano; Mimi Y Kim; Jane E Salmon
Journal:  Lupus Sci Med       Date:  2016-01-12
View more
  1 in total

1.  Maternal Thrombophilia and Recurrent Miscarriage - Is There Evidence That Heparin is Indicated as Prophylaxis against Recurrence?

Authors:  Ana-Luisa Stefanski; Christoph Specker; Rebecca Fischer-Betz; Wolfgang Henrich; Ekkehard Schleussner; Thomas Dörner
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-03-21       Impact factor: 2.915
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.